New Horizons in HSCT-TMA: Expert Perspectives and Pearls for Practice
This live educational event is intended for learners to be better able to understand the dynamic data evaluating diagnostic and care strategies for hematopoi…
This live educational event is intended for learners to be better able to understand the dynamic data evaluating diagnostic and care strategies for hematopoi…
Nicolas Girard, MD, compares the predictive value, mechanisms of action, and safety or efficacy profile of HER2-targeted TKIs vs ADCs in NSCLC.
Data from the TROPION-Breast01 trial support the FDA approval of datopotamab deruxtecan for those with metastatic HR–positive, HER2-negative breast cancer.
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of…
In this issue of Blood, Lee et al1 conclude that the brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine (BV-N-AD) regimen shows a tolerable safet
Additionally, the Chinese Society of Clinical Oncology and Chinese Anti-Cancer Association guidelines recommend the isatuximab regimen for this population.
Learn more about cervical cancer and find helpful resources
Take this survey powered by surveymonkey.com. Create your own surveys for free.
The video describes coil prolapse – a rare complication of embolization procedures.Objectives:1. Describe a coil prolapse2. Describe predisposing factors3. D…
Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, presents the updated results of the ENERGIZE-T study (NCT04770779), a Phase III open-label double-blind placebo-controlled study…
Our paid undergraduate summer scholarships offer undergraduate students a chance to gain hands-on cancer research experience.